PROCESS FOR PREPARING OLEFINS

Abstract: 4-Isobutylstyrene and other olefinic compounds corresponding to the formula C(R3)(R4)=C(R2)A are prepared by reacting an organic compound having the formula AX with a vinyl or substituted vinyl compound having the formula C(R3)(R4)=C(R2)H in the presence of a catalyst comprising (a) palladium or a palladium salt and (b) a ligand corresponding to formula (I) in which formulae A is aryl, substituted aryl, heteroaryl, substituted heteroaryl, benzyl, substituted benzyl, vinyl, or substituted vinyl; R2, R3, and R4 are independently selected from hydrogen, alkyl, cycloalkyl, alkyl-substituted cycloalkyl, aryl, substitued aryl, alkoxy, alkylthio, heteroaryl, substituted heteroaryl, alkanoyl, aroyl, substituted aroyl, heteroarylcarbonyl, substituted heteroarycarbonyl, trifluoromethyl, and halo; X is chloro, bromo, iodo, or diazonium; Ar is phenyl, substituted phenyl, naphthyl, or substituted naphthyl; R' and R" are independently selected from hydrogen, alkyl, aryl, or substituted aryl; and n is an interger of 3-6. The olefinic compounds prepared by the reaction may be carbonylated to the corresponding carboxylic compounds.

Description: PROCESS FOR PREPARING O EFTNS Field of the Invention The invention relates to a method for preparing substituted olefins by the palladium- catalyzed coupling of vinyl compounds with organic halides and to the subsequent preparation of carboxylic acids or esters. Background The palladium-catalyzed vinylation of organic halides provides a very convenient method for forming carbon-carbon bonds at unsubstituted vinylic positions. The reaction, reported by Heck (Palladium Reagents in Organic Syntheses. Academic Press, Canada 1985) can be used to prepare fine organics, pharmaceuticals, and specialty monomers. For example, the reaction allows a one-step synthesis of substituted styrenes from aryl bromides and is an excellent method for preparation of a wide variety of styrene derivatives. Heitz et al., Makromol Chem.. _ , 119 (1968). A new process for preparing aryl substituted aliphatic carboxylic acids or their alkyl esters is disclosed in U. S. Patent No. 5,315,026. A 1 -aryl substituted olefin is reacted with carbon monoxide in the presence of water or an alcohol at a temperature between 25 °C and 200°C. A mixture of palladium compound and a copper compound with an acid-stable cyclic phosphine having the formula: R ' A ^ C H-P ( A r ) 2 ( C H 2 ) n I „ \_ C H-R where R' is the same or different than R" and is hydrogen, alkyl or aryl, said aryl, either substituted or unsubstituted, and Ar is phenyl, naphthyl, substituted phenyl or substituted naphthyl and n is an integer from 3 to 6 is used as a catalyst. Description of the Preferred Embodiments Definitions In the following specification, the meaning of the substituent groups is as follows: "alkyl" means straight or branched chain alkyl having 1 to 20 carbon atoms and includes, for example, methyl, ethyl, propyl, isopropyl, butyl, isobutyl, secondary butyl, tertiary butyl, pentyl, isopentyl, neopentyl, hexyl, heptyl, octyl, 2-ethylhexyl, 1,1,3,3-tetramethylbutyl, nonyl, decyl, dodecyl, tetradecyl, hexadecyl, octadecyl and eicosyl, (for the purposes of this definition, "alkyl" may be replaced by "aliphatic". Such term includes "C, to C 6 alkyl" which is 1 to 6 linear or branched carbon atoms); "cycloalkyl" means cyclic alkyl having 3 to 7 carbon atoms and includes, e.g., cyclopropyl, cyclobutyl, cyclopentyl, cyclohexyl, and cycloheptyl; "aryl" means phenyl, napthyl, or biphenyl; "substituted aryl" means phenyl, naphthyl, or biphenyl substituted by at least one substituent selected from the group consisting of aroyl (as defined below), halogen (chlorine, bromine, fluorine or iodine), amino, nitro, hydroxy, alkyl, alkoxy (which means straight or branched chain alkoxy having 1 to 10 carbon atoms, and includes, for example, methoxy, ethoxy, propoxy, isopropoxy, butoxy, isobutoxy, secondary butoxy, tertiary butoxy, pentyloxy, isopentyloxy, hexyloxy, heptyloxy, octyloxy, nonyloxy and decyloxy), aryloxy including phenoxy and phenoxy substituted with halo, alkyl, or alkoxy, haloalkyl which means straight or branched chain alkyl having 1 to 8 carbon atoms which are substituted by at least one halogen, and includes, for example, chloromethyl, bromomethyl, fluoromethyl, iodomethyl, 2-chloroethyl, 2-bromoethyl, 2-fluoroethyl, 3-chloropropyl, 3-bromopropyl, 3- fluoropropyl, 4-chlorobutyl, 4-fluorobutyl, dichloromethyl, dibromomethyl, difluoromethyl, diiodomethyl, 2,2-dichloroethyl, 2,2-diibromoethyl, 2,2-difluoroethyl, 3,3-dichloropropyl, 3,3-difluoropropyl, 4,4-dichlorobutyl, 4,4-difluorobutyl, trichloromethyl, trifluoromethyl, 2,2,2-tri-fluoroethyl, 2,3,3-trifluoropropyl, 1,1,2,2-tetrafluoroethyl, and 2,2,3,3-tetrafluoro- propyl; "alkyl-substituted cycloalkyl" means that the cycloalkyl moiety is cyclic alkyl having 3 to 7 carbon atoms and the alkyl moiety is straight or branched chain alkyl having 1 to 8 carbon atoms, and includes, for example, cyclopropylmethyl, cyclobutylmethyl, cyclopentylmethyl, cyclohexylmethyl, cycloheptylmethyl, 2-cyclopropylethyl, 2-cyclopentyl- ethyl, 2-cyclohexylethyl, 3-cyclopropylpropyl, 3-cyclopentylpropyl, 3-cyclohexylpropyl, 4- cyclopropylbutyl, 4-cyclopentylbutyl, 4-cyclohexylbutyl, 6-cyclopropylhexyl, and 6-cyclo- hexylhexyl; "alkylthio" means a divalent sulfur with alkyl occupying one of the valencies and includes the groups methylthio, ethylthio, propylthio, butylthio, pentylthio, hexylthio, and octylthio; "heteroaryl" means 5 to 10 membered mono- or fused- hetero-aromatic ring which has at least one heteroatom and includes those selected from the group consisting of nitrogen, oxygen and sulfur, and includes, for example, 2-furyl, 3-furyl, 2-thienyl, 3-thienyl, 2-pyridyl, 3-pyridyl, 4-pyridyl, pyrazolyl; imidazolyl, pyrimidinyl, pyridazinyl, pyrazinyl, benzimi- dazolyl, quinolyl, oxazolyl, thiazolyl, and indolyl; "substituted heteroaryl" means 5 to 10 membered mono- or fused-heteroaromatic ring which has at least one heteroaromatic selected from the group consisting of nitrogen, oxygen and sulfur and which is substituted by at least one substituent selected from the group consisting of halogen, amino, nitro, hydroxy, alkyl, alkoxy and haloalkyl on the above- mentioned heteroaromatic nucleus; "alkanoyl" means alkanoyl having 2 to 18 carbon atoms and includes, for example, acetyl, propionyl, butyryl, isobutyryl, pivaloyl, valeryl, hexanoyl, octanoyl, lauroyl, and stearoyl; "aroyl" means benzoyl or naphthoyl; "substituted aroyl" means benzoyl or naphthoyl substituted by at least one substituent including those selected from the group consisting of halogen, amino, nitro, hydroxy, alkyl, alkoxy and haloalkyl on the benzene and naphthalene ring; "heteroarylcarbonyl" means that the heteroaryl moiety is 5 to 10 membered mono- or fused- heteroaromatic ring having at least one heteroatom selected from the group consisting of nitrogen, oxygen and sulfur as mentioned above, and includes, for example, furoyl, thinoyl, nicotinoyl, isonicotinoyl, pyrazolylcarbonyl, imidazolylcarbonyl, pyrimi- dinylcarbonyl, and benzimidazolyl-carbonyl; "substituted heteroarylcarbonyl" means the above-mentioned heteroaryl-carbonyl which is substituted by at least one substituent selected from the group consisting of halogen, amino, nitro, hydroxy, alkoxy and haloalkyl on the heteroaryl nucleus; and includes, for example, 2-oxo-l,3-dioxolan-4-ylmethyl, or 2-oxo-l,3-dioxan-5-yl; "vinyl" means an unsaturated substituent having at least one unsaturated double bond and having the formula CH 2 =CH-; "substituted vinyl" means the above vinyl substituent having at least one of the protons on the terminal carbon atom replaced with alkyl, cycloalkyl, alkyl-substituted cycloalkyl, aryl, substituted aryl, heteroaryl or substituted heteroaryl. In one embodiment of the present invention, olefin compounds are produced having the formula: R , R 2 C— c I I R 4 A where R 2 , R- and are the same or different and are individually hydrogen, alkyl, cycloalkyl, alkyl-substituted cycloalkyl, aryl either substituted or unsubstituted, alkoxy, alkylthio, heteroaryl either substituted or unsubstituted, alkanoyl, aroyl either substituted or unsubstituted, heteroarylcarbonyl either substituted or unsubstituted, trifluoromethyl or halo, and A is aryl, substituted aryl, heteroaryl, substituted heteroaryl, benzyl, substituted benzyl, vinyl or substituted vinyl. Preferably, in the compounds of Formula II, A is unsubstituted or substituted aryl, R 2 , R 3 and R 4 are hydrogen, C ,to C 6 alkyl, substituted or unsubstituted phenyl or trifluoromethyl. Most preferably A is phenyl substituted with alkyl (e.g., isobutyl) or naphthyl substituted with alkoxy (e.g., methoxy), R 2 , R and 4 R are hydrogen, methyl or trifluoromethyl, especially hydrogen. The compounds of Formula II are produced by the reaction of an organic halide of the Formula A-X where X is chloro, bromo, iodo, diazonium, triflate, or other leaving groups which can be found in organic textbooks, and A is as previously defined, with a vinyl or substituted vinyl compound of the formula /"' C=C / \ R 4 H where R 2 , R 3 and 1^ are as previously defined. The reaction, sometimes called a "vinylation" reaction, is typically carried out in the presence of a reaction promoting catalyst that is palladium metal or a palladium compound in which the palladium has a valence of zero, 1 or 2 and a cyclic ligand of the formula R " C H-P ( A r ) 2 ( C H 2 ) n I .. \ C H- where R' and R" are the same or different and are individually hydrogen, alkyl, aryl or substituted aryl, Ar is phenyl, naphthyl, substituted phenyl or substituted naphthyl and n is an integer from 3 to 6. Preferably, R' and R" are the same or different and are C, to C 6 alkyl, Ar is phenyl or naphthyl and n is 3 or 4. Most preferably, R' is methyl or ethyl, R" is C, to C 6 branched alkyl, Ar is phenyl and n is 4. Especially preferred is neomenthyldiphenyl- phosphine as the cyclic ligand. The vinylation reaction is carried out in the presence or in the absence of a solvent. When a solvent is used, it can be a polar solvent such as, for example, acetonitrile, tetrahydrofuran, dioxane, or dimethylformamide. Conditions for the vinylation reaction usually require an equimolar ratio of organic halide to vinyl or substituted vinyl compound, although an excess of vinyl compound is preferred. The catalyst/ligand are typically used at a ratio of 1 mol of organic halide to 0.0005 mol of palladium or palladium compound. The cyclic ligand is present in the same or higher molar proportion as the metal or metal compound. It should be noted that levels of palladium metal or palladium compound and ligand can be substantially higher (up to 10 times). When relatively inactive species of vinyl or halide are encountered, for example, highly substituted olefins and/or organic halides bearing strongly electron donating substituents may require these higher amounts of catalyst/ligand. Temperatures of reaction are quite modest, varying from 25 °C to 200°C (preferably 60°C to 150°C) with pressures (for the gaseous vinyl compounds) being from atmospheric up to 3000 psi (preferably 400 to 1000 psi). With the improved catalyst combination of the present invention, reaction times are unusually short, typically giving complete reaction in from 1 to 24 hours, typically 2 to 4 hours. Higher temperatures and pressures tend to cause decomposition of the olefin reactants and products and this should be avoided. The olefin formed in the reaction mixture is readily separated by conventional means, e.g., distillation or extraction with a non-polar solvent, e.g., liquid hydrocarbons like hexane having from 5 to 12 carbon atoms, both linear and branched. A further embodiment of the present invention is one in which the olefin compound of Formula II can be used with or without isolation (preferably without isolation) from the reaction mixture in the catalytic carboxylation step to produce compounds of Formula III H C i 1 f C C ( 0 ) 0 R . I l l I I R 4 A where R„ R 2 , R 3 , R 4 and A are as previously defined. The catalytic carboxylation of the compound of Formula II is conducted, at a temperature between 25 °C and 200°C, preferably 25°-120°C, and most preferably 25°- 100°C. Higher temperatures can also be used. It has been found that a small advantage in yield is obtained by gradually increasing the temperature within the preferred ranges during the course of the reaction. The partial pressure of carbon monoxide in the reaction vessel is at least one atmosphere (0 psig) at ambient temperature (or the temperature at which the vessel is charged). Any higher pressures of carbon monoxide can be used up to the pressure limits of the reaction apparatus. A pressure up to about 3000 psig is convenient in the process. More preferred is a pressure from 0 to 3000 psig at the reaction temperature and most preferred is a pressure from 0 to 1000 psig. It should be noted that the presence of oxygen is undesirable in the hydrocarboxylation reaction of this invention. Hence, an atmosphere of 100% carbon monoxide is most preferred to carry out this process. Various inert gases (e.g., nitrogen and argon) can, however, be incorporated in the reaction mass, the only criteria being that the process should not be slowed to the point of requiring exceptionally long periods to complete the reaction. The carboxylation is conducted in the presence of at least one mol of water or aliphatic alcohol per mol of the compound of Formula II; however, an excess is preferred in order to assist in driving the reaction to completion. Although there is no real upper limit to the amount of water or alcohol except that imposed by practicality (e.g. the size of the reaction vessel), an amount up to about 100 mols per mol of the compounds of Formula II is useful in the process. Further, controlling the amount of water or alcohol used in the process of this invention is advantageous in terms of producing the highest yields. Therefore, an amount from 1 to 50 mols of water or alcohol per mol of the compounds of Formula II is preferred, and an amount from 2 to 24 mols of water or alcohol per mol of the such olefinic compound is most preferred. The product of the reaction is a carboxylic acid (where R, is hydrogen) or carboxylic acid ester (where R, is alkyl) of Formula III. The present invention embraces any racemates and individual optical isomers of the compounds of Formula III having a chiral carbon atom. For example, when compounds of Formula III wherein the acid is 2-(6-methoxy-2-naphthyl)propionic acid, are subjected to resolution as taught in U. S. Patent 4,246,164, the analgesic compound naproxen is produced. Any alcohol which produces an ester of the carboxylic acid may be used in the practice of this invention. In a preferred embodiment, the C, to aliphatic alcohols are used. Examples of the alcohols to be used in this embodiment include methyl alcohol, ethyl alcohol, n-propyl alcohol, isopropyl alcohol, n-, iso-, sec-, and tert-butyl alcohols, the pentyl alcohols, (isoamyl alcohol, especially to form the naproxen ester), and the hexyl alcohols. Methyl alcohol is highly preferred, and ethyl alcohol is most highly preferred. Other alcohols, glycols, or aromatic hydroxy compounds may also be used. In the broadest sense, these alcohols provide a source of alkoxide ions for this reaction. However, any other "source of alkoxide ions" may also be used. The source of such alkoxide ions is from a compound selected from the group consisting of HC(OR,) 3 , (R) 2 C(OR,) 2 , HC(O)OR, , B(OR,) 3 , Ti(OR,) 4 and Al(OR,) 3 where R is hydrogen or individually the same or different than R, and R, is as previously defined. In a preferred embodiment of this invention, the carboxylation reaction is initiated under neutral conditions, i.e., with no added acid. It can also be performed in the presence of an added acid. When acids are added, such acids include sulfuric acid, phosphoric acid or sulfonic acids. A hydrogen halide acid such as hydrochloric or hydrobromic acid is preferred. The hydrogen halide may be added as a gas phase or as a liquid phase. Any concentration may be used. Hydrochloric acid is particularly preferred, at a concentration up to 10%; more highly preferred is a concentration from 10% to 30%. The amount of acid added is such as to provide up to 40 mols of hydrogen ion per mol of compound of Formula II; more preferred is an amount to provide up to 10 mols of hydrogen ion per mol of compound; the most preferred amount provides up to 4 mols of hydrogen ion per mol of the compounds of Formula II. The catalytic carboxylation process of this invention is conducted in the presence of a reaction-promoting quantity of (i) palladium metal or a palladium compound in which the palladium has a valence of zero, 1 or 2, or (ii) a mixture of a palladium metal or palladium compound and a copper compound, with (iii) the cyclic ligand of Formula I. The compounds of palladium and copper are sometimes referred to as palladium and copper salts. In one embodiment, palladium and copper compounds are inorganic salts and are added as a preformed complex of, for example, palladium(II) chloride or bromide, copper(II) chloride or bromide and carbon monoxide or any other similar complex. In a preferred embodiment, active catalytic species are formed in situ by the addition to the reaction mixture of the individual components, i.e., a ligand, a copper compound, and a palladium compound such as the inorganic salts of palladium (II) and copper(II). These inorganic salts include the chlorides, bromides, nitrates, sulfates, or acetates. In the most preferred embodiment, neomenthyldiphenylphosphine, copper(II) chloride, and palladium(II) chloride are used and are added individually or together, either simultaneously or sequentially. The palladium metal or the palladium compound or the mixture of palladium and copper compounds can be supported on carbon, silica, alumina, zeolite, clay and other polymeric materials and used as the heterogeneous catalysts. The amount of the mixture of copper and palladium compounds or of palladium metal or its compounds preferably employed is such as to provide from 4 to 8000 mols of the compound of Formula II per mol of the mixture of metal or metal salt; more preferred is an amount to provide from 20 to 2000 mols of the compounds of Formula II per mol of the metal salt mixture. The process of this invention is conducted in the presence of at least one mol of the cyclic ligand per mol of the mixture of the metal or metal salts. More preferably, 1 to 40 mols of ligand per mol of the mixture are present, and most preferably 1 to 20 mols of ligand per mol of the mixture are used. The presence of a solvent is not required in the process of this invention, although it may be desirable in some circumstances. Those solvents which can be used include one or more of the following: ketones, for example, acetone, methyl ethyl ketone, diethyl ketone, methyl n-propyl ketone, and acetophenone; linear, poly and cyclic ethers, for example, diethyl ether, di-n-propyl ether, di-n-butyl ether, ethyl n-propyl ether, glyme (the dimethyl ether of ethylene glycol), diglyme (the dimethyl ether of diethylene glycol), tetrahydrofuran, dioxane, and 1 ,3-dioxolane; and aromatic hydrocarbons, for example, toluene, ethyl benzene, and xylenes. Alcohols are also suitable as solvents, for example, methanol, ethanol, 1- propanol, 2-propanol, isomers of butanol, and isomers of pentanol. Acids and esters may also be used, such as formic or acetic acid or ethyl acetate. When an ester or an alcohol is used as solvent, the product is the corresponding ester of the carboxylic acid. Most highly preferred are ethers, especially tetrahydrofuran. When solvents are used, the amount can be up to 100 mL per gram of the compounds of Formula II, but the process is most advantageously conducted in the presence of 1 to 30 mL per gram of the compound of Formula II. In those specific embodiments of this invention in which an ester is produced, e.g. ibuprofen alkyl ester, the ester may be conveniently converted to the acid (ibuprofen itself) by conventional methods of hydrolysis. Base hydrolysis can also be employed if desired to produce pharmaceutically acceptable salts wherein the cation is sodium, potassium, calcium, hydrogen carbonate or a quaternary ammonium compound. Examples of compounds produced by use of the invention include ibuprofen; 2-(6- methoxy-2-naphthyl)propionic acid; 2-(3-fluoro-4-biphenylyl)-propionic acid (also known as flurbiprofen) and 2-(3-benzoylphenyl)propionic acid (also known as ketoprofen). As described herein the bromo precursor of each of the above compounds is reacted with ethylene in this presence of a base (e.g., triethyl amine) and a palladium catalyst (as described herein, including a ligand such as neomenthyldiphenylphosphine). The base should be selected to avoid beta hydride elimination under reaction conditions and should not react with the olefin or bromo precursor to any appreciable extent. The bromo precursor substitutes on the ethylene to provide the substituted olefin which is then carboxylated (using carbon monoxide and palladium catalyst as described herein) to produce the corresponding acid product (if water forms part or all of the solvent system) or the corresponding ester (if an alcohol such as methyl, ethyl or isoamyl alcohol) is used as all or part of the solvent. The above reactions can be exemplified as follows: I B U P R O F E N FLURB I PROFEN : KETOPROFEN NAPROXEN CH, NAPROXEN FENOPROFEN : In the above reactions the ethylene pressure should be 50 to 3000 psi (preferably 400 to 1000 psi), the temperature is 30°C to 200°C (preferably 60°C to 150°C). Temperatures and pressures are selected to minimize olefin decomposition. Palladium^ is used in the form of its salts (e.g., acetate or chloride) along with a ligand as described with the phosphine ligands being preferred. The bromo precursors are frequently commercially available and/or can be readily prepared by those skilled in the art. For example, Aldrich Chemical Company sells m- bromophenol and m-bromoanisole while Albemarle PPC (Paris, France) sells 6-methoxy-2- bromonaphthalene. The bromo precursors of ibuprofen can be prepared by bromination using standard Friedel-Crafts catalysts (e.g., zinc bromide or ferric bromide). The bromo precursor of ketoprofen can be prepared by bromination of methyl benzoate (or a similar lower hydrocarbon ester) using aluminum chloride followed by NaOH hydrolysis, conversion to the acid chloride (e.g., with SOCl 2 ) and reaction with benzene (again, using a Friedel- Crafts catalyst such as A1C1 3 ). In addition to the profen compounds described above, other profen compounds which can be prepared by use of this invention to convert the corresponding bromo precursors by reaction with ethylene include protizinic acid, tiaprofenic acid, indoprofen, benoxaprofen, carprofen, pirprofen, pranoprofen, alminoprofen, suprofen and loxoprofen. The follow examples are given to illustrate the process of this invention and are not intended as a limitation thereof. EXAMPLES NMDP = Neomenthyldiphenylphosphine IBS = 4-Isobutylstyrene BIBB = 4-Bromoisobutylbenzene DIBE = 1,1 -Bis(4-isobutylphenyl)ethylene DIBS = 4,4'-Diisobutylstilbene Example 1 Pd(OAc) 2 (11.0 mg, 0.0490 mmol) and NMDP (0J00 g, 0.308 mmol) were loaded to an autoclave (Hastelloy C, 100 mL) in a dry box. The reactor was assembled in the dry box and set up in the hood. CH 3 CN (12.5 mL), Et 3 N (12.5 mL) and BIBB (10.6 g, 49.7 mmol) were added via syringe. The reactor was purged with ethylene (2 x 150 psig) and then filled with ethylene (280 psig). The mixture was stirred at 120 - 125 °C for 2 h. GC analysis of an aliquot showed IBS (95.5 area%), DIBE (0.6%), and DIBS (4.0%). Example 2 Pd(OAc) 2 (11.0 mg, 0.0490 mmol) and NMDP (0.100 g, 0.308 mmol) were loaded to an autoclave (Hastelloy B, 100 mL) in a dry box. The reactor was assembled in the dry box and set up in the hood. CH 3 CN (12.5 mL), Et 3 N (12.5 mL) and BIBB (10.6 g, 49.7 mmol) were added via syringe. The reactor was purged with ethylene (2 x 150 psig) and then filled with ethylene (320 psig). The mixture was stirred at 100 - 105°C for 2 h. GC analysis of an aliquot showed IBS (97.6 area%), DIBE (0.1 %), and DIBS (2.4%). Example 3 Pd(OAc) 2 (11.0 mg, 0.0490 mmol) and NMDP (0J00 g, 0.308 mmol) were loaded to an autoclave (Hastelloy C, 100 mL) in a dry box. The reactor was assembled in the dry box and set up in the hood. CH 3 CN (12.5 mL), Et 3 N (12.5 mL) and BIBB (10.6 g, 49.7 mmol) were added via syringe. The reactor was purged with ethylene (2 x 150 psig) and then filled with ethylene (330 psig). The mixture was stirred at 80 - 85 °C for 4 h. GC analysis of an aliquot showed IBS (97.9 area%) and DIBS (2.0%). Example 4 f Comparative^ Pd(OAc) 2 (11.0 mg, 0.0490 mmol) and tø-Tol) P (94.0 mg, 0.309 mmol) were loaded to an autoclave (Hastelloy B, 100 mL) in a dry box. The reactor was assembled in the dry box and set up in the hood. CH 3 CN (12.5 mL), Et 3 N (12.5 mL) and BIBB (10.6 g, 49.7 mmol) were added via syringe. The reactor was purged with ethylene (2 x 150 psig) and then filled with ethylene (330 psig). The mixture was stirred at 80 - 85 °C for 8 h. GC analysis of an aliquot showed IBS (24.0 area%), BIBB (76.0%), and DIBS (trace). Example 5 (Comparative) Pd(OAc) 2 (11.0 mg, 0.0490 mmol) and (Cyclohexyl) 3 P (87.0 mg, 0.310 mmol) were loaded to an autoclave (Hastelloy B, 100 mL) in a dry box. The reactor was assembled in the dry box and set up in the hood. CH 3 CN (12.5 mL), Et 3 N (12.5 mL) and BIBB (10.6 g, 49.7 mmol) were added via syringe. The reactor was purged with ethylene (2 x 150 psig) and then filled with ethylene (300 psig). The mixture was stirred at 80 - 85 °C for 8 h. GC analysis of an aliquot showed no reaction. Example 6 fComparativel Pd(OAc) 2 (11.0 mg, 0.0490 mmol) and Ph 3 P (81.0 mg, 0.309 mmol) were loaded to an autoclave (Hastelloy B, 100 mL) in a dry box. The reactor was assembled in the dry box and set up in the hood. CH 3 CN (12.5 mL), Et 3 N (12.5 mL) and BIBB (10.6 g, 49.7 mmol) were added via syringe. The reactor was purged with ethylene (2 x 150 psig) and then filled with ethylene (320 psig). The mixture was stirred at 80 - 85 °C and monitored by GC. GC analysis of an aliquot in 8 h showed IBS (14.4 GC area%), BIBB (84.6%), and DIBS (trace). Example 7 Pd(OAc) 2 (5.0 mg, 0.022 mmol) and NMDP (45 mg, 0J4 mmol) were loaded to an autoclave (Hastelloy B, 100 mL) in a dry box. The reactor was assembled in the dry box and set up in the hood. CH 3 CN (14 mL), Et i (14 mL) and BIBB (11.8 g, 55 mmol) were added via syringe. The reactor was purged with ethylene (2 x 150 psig) and then filled with ethylene (280 psig). The mixture was stirred at 100 - 105°C for 4 h. GC analysis of an aliquot showed IBS (97.8 area %) and dimers (2.2%). Example 8 PdCl 2 (9.0 mg, 0.0510 mmol) and NMDP (0J00 g, 0.308 mmol) were loaded to an autoclave (Hastelloy C, 100 mL) in a dry box. The reactor was assembled in the dry box and set up in the hood. CH 3 CN (12.5 mL), Et 3 N (12.5 mL) and BIBB (10.7 g, 50.2 mmol) were added via syringe. The reactor was purged with ethylene (2 x 150 psig) and then filled with ethylene (300 psig). The mixture was stirred at 80 - 85 °C for 4 h. GC analysis of an aliquot showed IBS (98.2 area %), DIBE (0.1%), and DIBS (1.6%). Example 9 PdCl 2 (9.0 mg, 0.0510 mmol), NMDP (0J00 g, 0.308 mmol), and CaO (1.5 g, 26.7 mmol) were loaded to an autoclave (Hastelloy C, 100 mL) in a dry box. The reactor was assembled in the dry box and set up in the hood. DMF (30 mL) and BIBB (10.6 g, 49.7 mmol) were added via syringe. The reactor was purged with ethylene (2 x 150 psig) and then filled with ethylene (360 psig). The mixture was stirred at 80 - 85 °C for 6 h. GC analysis of an aliquot showed IBS (95.9 area %), BIBB (2.0%), DIBE (0.1%), and DIBS (2.1%). Example 10 PdCl 2 (9.0 mg, 0.0510 mmol) and NMDP (0J00 g, 0.308 mmol) were loaded to an autoclave (Hastelloy C, 100 mL) in a dry box. The reactor was assembled in the dry box and set up in the hood. DMF (20 mL), Et 3 N (7.5 mL) and BIBB (10.7 g, 50.2 mmol) were added via syringe. The reactor was purged with ethylene (2 x 150 psig) and then filled with ethylene (300 psig). The mixture was heated to 80 - 85 °C and the reactor was pressurized to 520 psig with ethylene. The mixture was stirred at this temperature for 2.5 h. GC analysis of an aliquot showed IBS (97.5 area %), DIBE (0.1%), and DIBS (2.5%). Example 11 PdCl 2 (7.0 mg, 0.0395 mmol) and NMDP (0J30 g, 0.401 mmol) were loaded to an autoclave (Hastelloy C, 100 mL) in a dry box. The reactor was assembled in the dry box and set up in the hood. DMF (15 mL), Et 3 N (10.2 g), and BIBB (21.0 g, 98.5 mmol) were added via syringe. The reactor was purged with ethylene (2 x 150 psig) and then filled with ethylene (300 psig). The mixture was stirred at 120°C for 1 h. GC analysis of an aliquot showed IBS (92.0 area %), BIBB (0.4%), DIBE (0.7%), and DIBS (6.9%). Example 12 Pd(OAc) 2 (11.0 mg, 0.0490 mmol), NMDP (0J00 g, 0.308 mmol), and 2-bromo-6- methoxynaphthalene (11.8 g, 49.8 mmol) were loaded to an autoclave (Hastelloy B, 100 mL) in a dry box. The reactor was assembled in the dry box and set up in the hood. CH 3 CN (20 mL) and Et 3 N (8 mL) were added via syringe. The reactor was purged with ethylene (2 x 150 psig) and then filled with ethylene (320 psig). The mixture was stirred at 80 - 85 °C for 5 h. GC analysis showed only 2-methoxy-6-vinylnaphthalene. The reaction mixture was cooled to room temperature and ethylene pressure was released. The mixture was filtered and the precipitate was washed with CH 2 C1 2 (150 mL). The combined filtrate was washed with HCl (IN, 2 x 50 mL), H 2 O (50 mL), and brine (50 mL). The organic layer was dried (Na 2 SO 4 ) and concentrated under reduced pressure to give a white solid (8.76 g, 96%): mp = 92 - 93°C.

Claims: Claims 1. A process which comprises preparing an olefinic compound corresponding to the formula C(R 3 )(R 4 )=C(R 2 )A by reacting an organic compound having the formula AX with a vinyl or substituted vinyl compound having the formula C^JO ^C R^H in the presence of a catalyst comprising (a) palladium or a palladium salt and (b) a ligand corresponding to the formula: R ' C H-P ( A r ) , ( C H 2 ) n I ., V C H-R to form an activated reaction mixture containing a substantial amount of said olefinic compound; in which formulas A is aryl, substituted aryl, heteroaryl, substituted heteroaryl, benzyl, substituted benzyl, vinyl, or substituted vinyl; R 2 , R 3 , and R 4 are independently selected from hydrogen, alkyl, cycloalkyl, alkyl-substituted cycloalkyl, aryl, substituted aryl, alkoxy, alkylthio, heteroaryl, substituted heteroaryl, alkanoyl, aroyl, substituted aroyl, heteroarylcarbonyl, substituted heteroarylcarbonyl, trifluoromethyl, and halo; X is chloro, bromo, iodo, or diazonium; Ar is phenyl, substituted phenyl, naphthyl, or substituted naphthyl; R' and R" are independently selected from hydrogen, alkyl, aryl, or substituted aryl; and n is an integer of 3-6. 2. The process of claim 1 wherein the palladium component of the catalyst is a Pd ++ salt and the ligand is neomenthyldiphenylphosphine. 3. The process of claim 1 wherein A is substituted or unsubstituted aryl and R 2 , R 3 , and R, are independently selected from hydrogen, alkyl containing 1 -6 carbons, trifluoro- methyl, and substituted or unsubstituted phenyl. 4. The process of claim 3 wherein A is isobutylphenyl, methoxynaphthyl, 3- fluorobiphenyl, 3-phenoxyphenyl, or 3-benzoylphenyl; and each of R 2 , R 3 , and R 4 is hydrogen. 5. The process of claim 4 wherein A is isobutylphenyl. 6. The process of claim 4 wherein A is methoxynaphthyl. 7. The process of any of the preceding claims including the additional step of reacting said olefinic compound with carbon monoxide to convert it to a carboxylic compound corresponding to the formula CH(R 3 )(R 4 )-C(R 2 )(A)-C(O)-OR , wherein R , is hydrogen or alkyl. 8. The process of claim 7 wherein the reaction with carbon monoxide is conducted by adding carbon dioxide and an aliphatic alcohol to the reaction mixture containing said olefinic compound so as to form an ester corresponding to the formula CH(R 3 )(R 4 )- C(R 2 )(A)-C(O)-OR , wherein R, is alkyl. 9. The process of claim 7 wherein the reaction with carbon monoxide is conducted by adding carbon dioxide and water to the reaction mixture containing said olefinic compound so as to form an acid corresponding to the formula CH(R 3 )(R 4 )-C(R 2 )(A)-C(O)- OR, wherein R, is hydrogen.

Inventors: WU TSE-CHONG, WU, TSE-CHONG
Applicants: ALBEMARLE CORP, ALBEMARLE CORPORATION
Application year: 1996
Main classification: C07B37
IPC codes: B01J31, C07B37, C07B61, C07C2, C07C15, C07C17, C07C25, C07C41, C07C43, C07C45, C07C49, C07C51, C07C67, C07C69, C07D213, C07D215